Application

15409238 · DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLINE CHEMOTHERAPEUTIC AGENTS

Filed 2017-01-18 · Abandoned The official file ↗ · Art unit 1642 · Examiner Nelson B Moseley II Easy · CPC A61K 9/1272 · Merrimack Pharmaceuticals, Inc. · Honigman LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

17.2 mo

to disposition 24.4 mo

Statutes raised

102

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.